These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 211963)

  • 1. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica].
    Capin NR; Capin R; Zamacona G; Ortiz-Ortiz L
    Arch Invest Med (Mex); 1978; 9 Suppl 1():291-6. PubMed ID: 211963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative pathway of complement by Entamoeba histolytica.
    Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
    Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
    Reed SL; Curd JG; Gigli I; Gillin FD; Braude AI
    J Immunol; 1986 Mar; 136(6):2265-70. PubMed ID: 2869084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entamoeba histolytica: surface proteolytic activity and its relationship with in vitro virulence.
    Araiza-Orozco LM; Avila EE; Muñoz ML; Arias-Negrete S
    Folia Parasitol (Praha); 1999; 46(3):161-7. PubMed ID: 10553649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An in vitro model for the quantitative study of E. histolytica virulence].
    Orozco E; Martínez-Palomo A; Lopez-Revilla R
    Arch Invest Med (Mex); 1978; 9 Suppl 1():257-60. PubMed ID: 211959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence of Entamoeba histolytica correlates with the capacity to develop complement resistance.
    Mogyoros M; Calef E; Gitler C
    Isr J Med Sci; 1986 Dec; 22(12):915-7. PubMed ID: 2883155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Axenic cultures of Mexican strains of E. histolytica HM2: IMSS and HM3: IMSS].
    de la Torre M; de la Hoz R; Filloy L
    Arch Invest Med (Mex); 1974; 5 SUPPL 2():279-82. PubMed ID: 4376910
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
    Calderon J; Schreiber RD
    Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of pathogenic and nonpathogenic Entamoeba histolytica with human complement.
    Reed SL; Gault M; Gillin FD; Gigli I; Braude AI; Curd JG; Sargeaunt PG
    Arch Invest Med (Mex); 1987; 18(2):141-9. PubMed ID: 2889433
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entamoeba histolytica inhibits the respiratory burst of polymorphonuclear leukocytes.
    Arbo A; Hoefsloot M; Ramírez A; Ignacio Santos J
    Arch Invest Med (Mex); 1990; 21 Suppl 1():57-61. PubMed ID: 2136504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysozyme and complement-dependent lysis of Entamoeba histolytica. Inhibition by leupeptin.
    Mogyoros M; Fishelson Z; Gitler C
    Isr J Med Sci; 1986 Dec; 22(12):918-20. PubMed ID: 2883156
    [No Abstract]   [Full Text] [Related]  

  • 13. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
    Liang-Takasaki CJ; Grossman N; Leive L
    J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.
    Reed SL; Keene WE; McKerrow JH; Gigli I
    J Immunol; 1989 Jul; 143(1):189-95. PubMed ID: 2543700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.
    Reed SL; Gigli I
    J Clin Invest; 1990 Dec; 86(6):1815-22. PubMed ID: 2254446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bacterial association on virulence of Entamoeba histolytica to baby hamster kidney cell monolayers.
    Ghosh PK; Gupta S; Naik S; Ayyagari A; Naik SR
    Indian J Exp Biol; 1998 Sep; 36(9):911-5. PubMed ID: 9854433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro sensitivity of Entamoeba histolytica to metronidazole].
    Aguirre-Cruz ML; Valadez-Salazar A; Muñoz O
    Arch Invest Med (Mex); 1990; 21 Suppl 1():23-6. PubMed ID: 2136490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entamoeba histolytica: mechanism of decrease of virulence of axenic cultures maintained for prolonged periods.
    Olivos A; Ramos E; Nequiz M; Barba C; Tello E; Castañón G; González A; Martínez RD; Montfort I; Pérez-Tamayo R
    Exp Parasitol; 2005 Jul; 110(3):309-12. PubMed ID: 15955329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intestinal bacteria on the virulence of Entamoeba histolytica.
    Anaya-Velázquez F; Padilla-Vaca F
    Arch Med Res; 1992; 23(2):183-5. PubMed ID: 1340289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
    Ferrante A; Rowan-Kelly B
    Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.